Parkinson's disease is a chronic neurodegenerative disease characterized by the
accumulation of misfolded alpha-synuclein protein (Lewy bodies) in dopaminergic neurons …

Parkinson's disease (PD) is the second most common neurodegenerative disease
characterized by motor dysfunction. Growing evidence has demonstrated that gut dysbiosis …

There is increasing evidence highlighting the potential role of the gut-brain axis in the
pathogenesis of Parkinson's disease (PD) and on the use of probiotics as a therapeutic …

Gut microbiota (GM) dysbiosis plays key roles in aggravating Parkinson's disease (PD) and
discovery of agents targeting GM may open new avenues for PD therapy. This study aims to …

Probiotics have been defined as “living microorganisms that create health benefits in the
host when taken in sufficient amounts. Recent developments in the understanding of the …

Background Alzheimer's disease (AD) and Parkinson's disease (PD) are two of the most
common neurodegenerative diseases, and mild cognitive impairment (MCI) is considered a …

The bidirectional interaction between the gut microbiota (GM) and the Central Nervous
System, the so-called gut microbiota brain axis (GMBA), deeply affects brain function and …

Metabolism and nutrition have a significant role in epigenetic modifications such as DNA
methylation, which can influence gene expression. Recently, it has been suggested that …

The use of oral agents that can modify the gut microbiota (GM) could be a novel preventative
or therapeutic option for Parkinson's disease (PD). Maslinic acid (MA), a pentacyclic …

The human microbiota is believed to influence health. Microbiome dysbiosis may be linked
to neurological conditions like Alzheimer's disease, amyotrophic lateral sclerosis, and …